查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球心臟導管市場-2022-2029
市場調查報告書
商品編碼
1146403

全球心臟導管市場-2022-2029

Global Cardiac Catheters Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

心導管市場規模預計將在 2021 年達到 129.5 億美元，在 2029 年達到 7.028 億美元，在預測期間（2022-2029 年）以 7.48% 的複合年增長率增長。

心臟導管是用於分析心臟瓣膜以及引導和可視化冠狀動脈的儀器。該產品是一種細而柔韌的管子，用於在血管成形術和支架植入等心血管手術期間將設備引導到人體血管中。心導管插入術的需求量很大，因為它比開放手術提供的侵入性更小。

市場動態

由於心臟病患病率增加、生活方式改變和飲食失調以及過度飲酒和吸煙帶來的心血管問題，全球心導管插入術市場正在快速增長。 .為此，也出現了動脈阻塞、中風等需要手術治療的疾病。

心血管疾病患病率上升推動市場增長

血管成形術被推薦用於治療周圍血管疾病。在此過程中，使用心臟導管探查受影響的動脈並使其重新通暢，以使動脈壁中的阻塞變平。根據美國心臟協會的一項研究，到 2020 年，將有 9210 萬美國人患有某種形式的 CVD，這使得 CVD 成為美國的頭號死因，而不是癌症和其他慢性疾病。

在世界發展中國家，老年人口的增加是主要問題之一。此外，預計在預期的時期內，老年人慢性病的患病率將會增加，例如主動脈疾病、靜脈血栓栓塞和外周動脈疾病。根據美國疾病控制和預防中心的數據，到 2020 年，全球 55 至 65 歲的人口中將有超過 19.1% 的人患有外周血管疾病，據推測約有 27% 的男性和超過 21% 的女性會受到影響。老年人最集中的地區是亞太地區，而且這一數字正以歷史最高水平增長。

手術和導管的高成本預計將阻礙市場增長

先進導管的高成本可能會限制行業的擴張。越來越多的患者接受導管插入術，患有慢性和心血管疾病，如尿失禁、腎衰竭和冠心病，需要創新導管。然而，這些情況下導管手術的高成本可能會降低低收入國家的導管穿透率。

此外，導管和必要配件的高成本可能會阻礙市場擴張。在收入水平相對較低的不發達國家，導管插入術的高成本可能會限制市場增長。因此，中低收入國家可能很難推出如此昂貴的產品。因此，這些先進設備的高價格可能會在估計數年內抑制導管市場的擴張。

COVID-19 影響分析

COVID-19 疫情將對全球導管行業的增長產生短期負面影響，因為治療、診斷和手術等服務被暫停以阻止 COVID-19 疾病的傳播。預計。據國家醫學圖書館稱，約旦已實施了與 COVID-19 相關的嚴格封鎖措施。心血管導管插入術干預量在嚴格封鎖期間急劇下降，在部分放鬆封鎖後逐漸增加。然而，隨著政府和醫療機構加強對 COVID-19 患者的醫療護理，預計醫院使用導管的頻率將會增加。導管被用於治療確診為 COVID-19 的患者。

全球心臟導管市場 - 行業分析

全球心臟導管市場提供基於波特五力、監管分析、供應鏈分析和定價分析、報銷政策、技術進步和 PEST 分析等各種行業因素的市場深入分析。

細分分析

在全球心臟導管市場中，PTA 球囊導管部分預計將佔據最大的市場份額

經皮腔內血管成形術稱為 PTA。用於微創導管治療的 PTA 球囊導管在尖端配備了一個可充氣的“球囊”。這種方法擴大了狹窄血管的入口。將放氣的球囊插入狹窄處，短暫充氣，然後再次放氣並取出。 PTA 球囊的大小、長度和形狀取決於所用血管的解剖結構。使用 PTA 球囊導管治療外周血管病變有兩種方法。一種方法是打開阻塞血管的內腔。這個過程被稱為“普通舊球囊血管成形術”（POBA）。另一種方法是擴張支架來治療阻塞的血管。

此外，PTA 球囊導管產量的增加和 FDA 產品批准的增加預計將刺激全球市場的擴張。例如，美國 FDA 於 2018 年 4 月批准了由 Medtronic Inc. 製造的 PACT Admiral Paclitaxel 塗層經皮腔內血管成形術 (PTA) 球囊導管。

按地區分析

北美在全球心導管市場佔有最大的市場份額

2021 年，北美主導了全球心導管插入術市場。這一巨大的收入份額主要是由於泌尿系統疾病、腎衰竭的患病率上升以及高素質外科醫生的數量不斷增加。例如，美國疾病控制和預防中心 (CDC) 估計，美國每 7 名成年人中就有 1 人或超過 3700 萬人患有慢性腎病。預計此類疾病的增加將增加對使用這些設備的導管插入術的需求。美國泌尿外科協會 (AUANET) 估計，2020 年美國將有 13,352 名全職泌尿科醫生。此外，心導管術住院患者人數的增加有望帶動國內市場的擴大。例如，NCBI 估計美國每年進行超過 100 萬次心導管插入術。此外，大公司的擴張將增加消費者需求和產品採用率。因此，由於上述原因，預計對導管治療的需求將會增加。

競爭格局

心導管市場是一個競爭激烈的市場，行業參與者紛紛進入市場。對全球市場增長做出貢獻的主要心導管術廠商有 Becton Dickinson & Company、波士頓科學公司、Bardo Medical、B. Braun Melsungen AG、Teleflex Corporation、強生公司、美敦力公司、Edwards Lifesciences Ltd.、Vascular Solutions, Inc ., 和雅培實驗室。領先公司正在為全球心導管市場的增長採用新產品開發和擴張戰略。例如，強生醫療器械公司於 2020 年 8 月 13 日宣布，Biosense Webster 的 QDot Micro 射頻消融導管已獲得歐洲 CE 標誌的批准。

全球心導管市場 - 值得關注的主要參與者

美敦力PLC

概述 Medtronic 是一家製造和銷售醫療設備的美國公司，在美國開展業務，總部位於美國明尼阿波利斯。它在大約 140 個國家開展業務，擁有 90,000 名員工。

產品組合 Export Advance 抽吸導管在最重要的時候提供一致的高性能抽吸，恢復血流並保護患者。

本研究報告為全球心導管插入術市場提供大約 45 多個市場數據表、40 多個圖和 180 頁的組成。

內容

第 1 章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按產品類型劃分的市場細分
  • 按應用劃分的市場細分
  • 最終用戶的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
    • 促進因素
      • 心臟病和老年人口的增加
      • 增加研發和高投入
      • 監管批准數量增加
      • 提高醫療保健意識
      • 優惠的保險報銷政策
    • 抑制因素
      • 高昂的手術費用和導管費用
      • 導管相關副作用
      • 缺乏熟練的專業人員
  • 影響分析

第 5 章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 監管分析
  • 定價分析
  • 保險報銷分析
  • 未滿足的需求分析

第 6 章按產品類型

  • 電生理導管
  • PTCA 球囊導管
  • IVUS 導管
  • PTA 球囊導管
  • 其他

第 7 章按應用程序

  • 冠狀動脈成形術
  • 球囊切開術
  • 導管消融
  • 雙極起搏
  • 左心/右心導管術
  • 其他

第 8 章最終用戶

  • 醫院
  • 門診手術中心
  • 診所

第 9 章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 10 章競爭格局

  • 競爭場景
  • 按產品類型進行的投資組合比較分析
  • 市場定位/市場份額分析
  • 併購分析

第 11 章公司簡介

  • Abbott Laboratories
    • 公司簡介
    • 按產品類型劃分的產品組合和內容
    • 主要亮點
    • 財務摘要
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Bard Medical
  • B. Braun Melsungen AG
  • Teleflex Incorporated
  • Johnson & Johnson
  • Medtronic, Inc.
  • Edwards Lifesciences Corp.
  • Vascular Solutions, Inc.

第 12 章全球心臟導管市場-DataM

簡介目錄
Product Code: DMMD1452

Market Overview

Cardiac Catheters Market size was valued US$ 12.95 billion in 2021 and is estimated to reach US$ 702.8 million by 2029, growing at a CAGR of 7.48% during the forecast period (2022-2029).

Cardiac catheters are instruments used for heart valve analysis or for directing and visualizing the coronary arteries. The product is a thin, flexible tube that is used to guide equipment through the body's blood vessels during cardiovascular treatments like angioplasty and stenting. Since they offer a less invasive interventional method than open surgery, cardiac catheters are in high demand.

Market Dynamics

The global cardiac catheters market is growing due to an increase in the prevalence of heart ailments, cardiovascular issues brought on by altered lifestyle patterns, poor dietary practices, and excessive alcohol and tobacco use, the market for cardiac catheters is growing at a rapid rate. This has further resulted in artery obstruction and stroke, both of which necessitate surgery.

Rising prevalence of cardiovascular diseases drives the growth of the market

For the treatment of peripheral vascular disorders, angioplasty is advised. During this operation, the afflicted artery is examined using a cardiac catheter, which reopens the artery and flattens the blockage in the artery wall. In contrast to cancer and other chronic diseases, the American Heart Association research estimates that 92.1 million Americans were living with some type of CVD in 2020 and that CVD is the leading cause of death in the nation.

One of the main issues in developing nations worldwide is the growing senior population. Additionally, an expected period of time would see a growth in the prevalence of chronic diseases in geriatric individuals, including aortic disease, venous thromboembolism, peripheral arterial disease, etc. In 2020, more than 19.1% of the world's population of seniors aged 55 to 65 had peripheral vascular disease, with about 27% of men and more than 21% of women affected, according to a report from the Centers for Disease Control and Prevention. The largest concentration of senior citizens is in Asia and the Pacific, and their numbers are growing at an unprecedented rate.

The high cost of surgical procedures and catheters is expected to hamper the market growth

The expensive cost of sophisticated catheters could limit industry expansion. A growing proportion of patients undergoing catheterization operations need innovative catheters because they have chronic and cardiovascular disorders like urine bladder, renal failure, and coronary heart disease. However, the adoption rate of catheters may decline throughout low-income countries as a result of the expensive catheterization operations for these disorders.

The expensive price of these gadgets and necessary accessories could limit market expansion. Market growth in underdeveloped nations with relatively low income levels may be constrained because to the high costs involved with catheterization procedures. As a result, it might be challenging for middle-income and low-income countries to adopt such expensive goods. Therefore, the high price of these advanced devices could restrain the expansion of the catheters market over the estimated year.

COVID-19 Impact Analysis

Due to on-hold services, such as treatment, diagnostic, and surgical services, to stop the spread of COVID-19 disease, it is projected that the COVID-19 epidemic will have a short-term negative impact on the growth of the global catheters industry. Jordan implemented a severe COVID-19-related lockout, according to the National Library of Medicine. Cardiovascular catheterization procedure volumes drastically decreased during the rigorous lockdown and gradually increased following a partial relaxation of the lockdown. However, as the government and healthcare organisations continue to enhance medical care for COVID-19 patients, catheters will be utilised more frequently in hospitals. Catheters are being used to treat the patients whose COVID-19 diagnoses were verified.

Global Cardiac Catheters Market - Industry Analysis

The global cardiac catheters market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis and pricing analysis, reimbursement policies, technological advancements, PEST analysis.

Segment Analysis

The PTA balloon catheter segment is expected to hold the largest market share in global cardiac catheters market

Percutaneous transluminal angioplasty is referred to as PTA. The PTA balloon catheter, used in a minimally invasive catheterization treatment, includes an inflatable "balloon" at its tip. The narrowed vascular entrance is widened with this method. The deflated balloon is placed in the constricted area, briefly inflated, and then deflated once more for removal. The anatomy that PTA balloons are designed to treat determines the many sizes, lengths, and shapes that are available. Peripheral vascular lesions can be treated with PTA balloon catheters in two different ways. One method is to widen the lumen of a blood artery that is blocked. This procedure is known as "plain-old balloon angioplasty" (POBA). The second application is for treating vascular blockages by expanding stents.

Additionally, it is anticipated that rising PTA balloon catheter production and rising FDA product approvals will fuel the expansion of the global market. For instance, the U.S. FDA approved the PACT Admiral Paclitaxel coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter manufactured by Medtronic Inc. in April 2018.

Geographical Analysis

North America region holds the largest market share in the global cardiac catheters market

North America was held a dominant position in the global cardiac catheters market in 2021. This large revenue share is mainly due to the rising prevalence of urological illnesses, renal failure, and the abundance of highly qualified surgeons, among other things. For instance, every seventh adult in the United States, or more than 37 million people, is projected to have chronic kidney disease, according to estimates from the Centers for Disease Control and Prevention (CDC). It is anticipated that the rising prevalence of diseases would increase the demand for catheterization operations, which employ these devices. The American Urological Association (AUANET) estimates that there will be 13,352 urologists working full-time in the United States in 2020. Additionally, it is anticipated that rising cardiac catheterization hospitalizations will promote market expansion in the nation. For instance, the NCBI estimates that more than 1,000,000 cardiac catheterization operations are carried out each year in the United States. Major players' presence in the area will also increase consumer demand and adoption rates for the products. Therefore, it is anticipated that the aforementioned causes will increase demand for catheterization procedures.

Competitive Landscape

The cardiac catheters market is highly competitive, owing to big market players in the industry. The key cardiac catheters players which are contributing to the growth of the global market include Becton Dickinson and Company, Boston Scientific Corporation, Bard Medical, B. Braun Melsungen AG, Teleflex Incorporated, Johnson & Johnson, Medtronic Plc, Edwards Lifesciences Corp, Vascular Solutions, Inc, Abbott Laboratories. The major players are adopting new product development and expansion strategies for global growth in the cardiac catheters market. For instance, Johnson & Johnson Medical Devices announced on August 13, 2020, that the QDot Micro radiofrequency ablation catheter from Biosense Webster has been granted European CE mark approval.

Global Cardiac catheters Market - Key Companies to Watch

Medtronic Plc:

Overview: Medtronic plc is an American company that operates in U.S. and manufactures and markets medical device headquarters in Minneapolis, US. It is operational in around 140 countries and 90,000 people are employed there.

Product Portfolio: Export Advance aspiration catheter delivers consistent, high-performing aspiration power when it matters most restoring flow and protecting patients.

The global cardiac catheters market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by End-user
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rise in the prevalence of cardiac diseases and geriatric population
      • 4.1.1.2. Increase in R&D and high investments
      • 4.1.1.3. The increasing number of regulatory approvals
      • 4.1.1.4. Increasing awareness of healthcare
      • 4.1.1.5. Favorable reimbursement policies
    • 4.1.2. Restraints
      • 4.1.2.1. The high cost of surgical procedures and catheters
      • 4.1.2.2. The side effects associated with catheters
      • 4.1.2.3. Lack of skilled professionals
  • 4.2. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Unmet Needs

6. By Product type

  • 6.1. Introduction
  • 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
  • 6.3. Market Attractiveness Index, By Product type
    • 6.3.1. Electrophysiology Catheters *
      • 6.3.1.1. Introduction
      • 6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2019-2026
    • 6.3.2. PTCA Balloons Catheters
    • 6.3.3. IVUS Catheters
    • 6.3.4. PTA Balloons Catheters
    • 6.3.5. Others

7. By Application

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 7.3. Market Attractiveness Index, By Application
    • 7.3.1. Coronary angioplasty *
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2019-2026
    • 7.3.2. Balloon septostomy
    • 7.3.3. Catheter ablation
    • 7.3.4. Bipolar pacing
    • 7.3.5. left/right heart catheterization
    • 7.3.6. others

8. By End-user

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
  • 8.3. Market Attractiveness Index, By End-user
    • 8.3.1. Hospitals *
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2019-2026
    • 8.3.2. Ambulatory Surgical Centers
    • 8.3.3. Clinics

9. By Region

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.3. Market Attractiveness Index, By Region
  • 9.4. North America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. U.S.
      • 9.4.6.2. Canada
      • 9.4.6.3. Mexico
  • 9.5. Europe
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. Germany
      • 9.5.6.2. U.K.
      • 9.5.6.3. France
      • 9.5.6.4. Italy
      • 9.5.6.5. Spain
      • 9.5.6.6. Rest of Europe
  • 9.6. South America
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.6.7. Brazil
    • 9.6.8. Argentina
    • 9.6.9. Rest of South America
  • 9.7. Asia Pacific
    • 9.7.1. Introduction
    • 9.7.2. Key Region-Specific Dynamics
    • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 9.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.7.6.1. China
      • 9.7.6.2. India
      • 9.7.6.3. Japan
      • 9.7.6.4. Australia
      • 9.7.6.5. Rest of Asia Pacific
  • 9.8. Middle East and Africa
    • 9.8.1. Introduction
    • 9.8.2. Key Region-Specific Dynamics
    • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Comparative Product type Portfolio Analysis
  • 10.3. Market Positioning/Share Analysis
  • 10.4. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Abbott Laboratories*
    • 11.1.1. Company Overview
    • 11.1.2. Product type Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Becton Dickinson and Company
  • 11.3. Boston Scientific Corporation
  • 11.4. Bard Medical
  • 11.5. B. Braun Melsungen AG
  • 11.6. Teleflex Incorporated
  • 11.7. Johnson & Johnson
  • 11.8. Medtronic, Inc.
  • 11.9. Edwards Lifesciences Corp.
  • 11.10. Vascular Solutions, Inc.

LIST NOT EXHAUSTIVE

12. Global Cardiac Catheters Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us